DK1619185T3 - 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf - Google Patents

4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf

Info

Publication number
DK1619185T3
DK1619185T3 DK04729502.7T DK04729502T DK1619185T3 DK 1619185 T3 DK1619185 T3 DK 1619185T3 DK 04729502 T DK04729502 T DK 04729502T DK 1619185 T3 DK1619185 T3 DK 1619185T3
Authority
DK
Denmark
Prior art keywords
difluoro
tetrahydro
salt
benzazepine derivative
benzazepine
Prior art date
Application number
DK04729502.7T
Other languages
English (en)
Inventor
Hiroyuki Koshio
Issei Tsukamoto
Akio Kakefuda
Seijiro Akamatsu
Chikashi Saitoh
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Application granted granted Critical
Publication of DK1619185T3 publication Critical patent/DK1619185T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04729502.7T 2003-04-28 2004-04-26 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf DK1619185T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003123032 2003-04-28
JP2003401126 2003-12-01
PCT/JP2004/005998 WO2004096775A1 (ja) 2003-04-28 2004-04-26 4,4-ジフルオロ-1,2,3,4-テトラヒドロ-5h-1-ベンゾアゼピン誘導体又はその塩

Publications (1)

Publication Number Publication Date
DK1619185T3 true DK1619185T3 (da) 2011-07-18

Family

ID=33422056

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04729502.7T DK1619185T3 (da) 2003-04-28 2004-04-26 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt deraf

Country Status (17)

Country Link
US (2) US7183271B2 (da)
EP (1) EP1619185B1 (da)
KR (1) KR100882154B1 (da)
AT (1) ATE512951T1 (da)
AU (1) AU2004234258B2 (da)
BR (1) BRPI0409718A (da)
CA (1) CA2521492C (da)
DK (1) DK1619185T3 (da)
IL (1) IL171332A (da)
MX (1) MXPA05011521A (da)
NO (1) NO333505B1 (da)
NZ (1) NZ542815A (da)
PL (1) PL1619185T3 (da)
PT (1) PT1619185E (da)
RU (1) RU2326868C2 (da)
SI (1) SI1619185T1 (da)
WO (1) WO2004096775A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
RU2326868C2 (ru) 2003-04-28 2008-06-20 Астеллас Фарма Инк. Производное 4,4-дифтор-1,2,2,4-тетрагидро-5н-1-бензазепина или его соль
JP4754566B2 (ja) 2005-07-22 2011-08-24 持田製薬株式会社 新規なヘテロシクリデンアセトアミド誘導体
KR20140143461A (ko) 2007-08-06 2014-12-16 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
SI2712622T1 (sl) * 2008-05-21 2016-10-28 Ferring B.V. Orodisperzibilni dezmopresin za povečanje začetnega obdobja spanja nemotenega z nokturijo
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US9598373B2 (en) 2012-06-11 2017-03-21 Tacurion Method for producing 4,4,7-trifluoro-1,2,3,4-tetrahydro-5H-1-benzazepine compound and intermediate used in the method
MX2019000536A (es) 2016-07-14 2019-04-01 Pfizer Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI960867A7 (fi) * 1993-08-26 1996-02-26 Yamanouchi Pharma Co Ltd Bentsatsepiinijohdannainen, sen farmaseuttinen seos ja välituote
CA2192928C (en) 1994-06-15 2010-10-26 Hidenori Ogawa Benzoheterocyclic derivatives
JPH11349570A (ja) 1994-06-15 1999-12-21 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環誘導体
JP3215910B2 (ja) * 1994-06-15 2001-10-09 大塚製薬株式会社 ベンゾヘテロ環誘導体
JPH09221476A (ja) * 1995-12-15 1997-08-26 Otsuka Pharmaceut Co Ltd 医薬組成物
TW359669B (en) 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives
JPH09221475A (ja) 1996-02-13 1997-08-26 Yamanouchi Pharmaceut Co Ltd 新規なオキシム誘導体
AR011913A1 (es) 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
JP2926335B2 (ja) 1997-06-13 1999-07-28 大塚製薬株式会社 医薬組成物
JP2001512120A (ja) 1997-07-30 2001-08-21 アメリカン・ホーム・プロダクツ・コーポレイション 三環系バソプレシンアゴニスト
CN1183134C (zh) 1997-07-30 2005-01-05 惠氏公司 三环后叶加压素激动剂
US6547395B1 (en) 1998-02-06 2003-04-15 Wavefront Sciences, Inc. Methods of measuring moving objects and reducing exposure during wavefront measurements
CA2358894A1 (en) 1999-02-04 2000-08-10 American Home Products Corporation Tricyclic pyridine n-oxides vasopressin agonists
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
EP1445253B1 (en) 2001-11-16 2009-08-05 Astellas Pharma Inc. 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
RU2326868C2 (ru) 2003-04-28 2008-06-20 Астеллас Фарма Инк. Производное 4,4-дифтор-1,2,2,4-тетрагидро-5н-1-бензазепина или его соль

Also Published As

Publication number Publication date
CA2521492A1 (en) 2004-11-11
RU2326868C2 (ru) 2008-06-20
EP1619185A1 (en) 2006-01-25
NO20055602D0 (no) 2005-11-25
AU2004234258A1 (en) 2004-11-11
PT1619185E (pt) 2011-08-25
US20060122170A1 (en) 2006-06-08
NO20055602L (no) 2006-01-24
BRPI0409718A (pt) 2006-05-02
NZ542815A (en) 2009-01-31
ATE512951T1 (de) 2011-07-15
MXPA05011521A (es) 2006-01-23
KR20060007402A (ko) 2006-01-24
SI1619185T1 (sl) 2011-09-30
US7183271B2 (en) 2007-02-27
AU2004234258B2 (en) 2009-04-09
EP1619185B1 (en) 2011-06-15
WO2004096775A1 (ja) 2004-11-11
US7807664B2 (en) 2010-10-05
KR100882154B1 (ko) 2009-02-06
RU2005136863A (ru) 2006-04-20
US20070167429A1 (en) 2007-07-19
NO333505B1 (no) 2013-06-24
CA2521492C (en) 2010-09-21
PL1619185T3 (pl) 2011-12-30
IL171332A (en) 2011-03-31
EP1619185A4 (en) 2008-07-23

Similar Documents

Publication Publication Date Title
GB0318447D0 (en) Therapeutic agents
DE60332137D1 (en) Cyclohexyl-sulphone als gamma-sekretase-inhibitoren
DE60107449D1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
ECSP034600A (es) Compuestos de lactama
MXPA05012323A (es) Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
EP1591120A4 (en) RECEPTOR AGONISTS
MXPA05012268A (es) N-arilsulfonilpiperidinas enlazadas como inhibidores de la gamma-secretasa.
ATE527238T1 (de) Mittel mit wirkung gegen sichelzellenanämie
DK1385515T3 (da) Spiropyrazole forbindelser
DE602004024770D1 (de) Substituierte 8-perfluoro-6,7,8,9-tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate
DK1222922T3 (da) Fremgangsmåde til stabilisering af benzimidazolforbindelser
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
GB0423405D0 (en) Organic compounds
PT1578741E (pt) Compostos aromáticos como agentes antiinflamatórios, imunoreguladores e antiproliferativos
NO20054787L (no) Indenderivater som farmasotiske midler
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
ATE432935T1 (de) N-(1,2,4-triazoloazinyl)thiophensulfonamid- verbindungen als herbizide
NO20055602L (no) 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepin-derivat og salt derav
NL1025709A1 (nl) 3-(1-[3-(1,3-Benzothiazol-6-yI)propylcarbamoyl]cycloalkyI)propaanzuurderivaten Derivatives als NEP-remmers.
ATE410428T1 (de) Pyrroloä2,1-cüä1,4übenzodiazepine als vasopressin-agonisten
BRPI0500536A (pt) Composição antimicrobiana
DE50203896D1 (de) Oxazin(thi)onverbindungen als fungizide
DE60308663D1 (de) Verwendung eines neuen mittels zur verhütung von infektionen
DE60211018D1 (de) Fungizide thiazolderivate
ITVR20020007U1 (it) Capo d'abbigliamento, particolarmente per karting